REG - Inspiration Health - Appointment of Chief Executive Officer

Inspiration HealthcareAnnouncement

12/12/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241212:nRSL7668Pa&default-theme=true

RNS Number : 7668P  Inspiration Healthcare Group PLC  12 December 2024

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Appointment of Chief Executive Officer

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces the appointment of Harout Rafi ("Raffi") Stepanian as CEO
and a Director of the Company, effective from 8 January 2025.  Roy Davis will
then return to the role of Non-Executive Chairman.

 

Raffi is an experienced and commercially focused healthcare industry
professional, with extensive operational experience within fast-growing
international medical device companies. His areas of expertise include
respiratory, anaesthesia and monitoring and he has a reputation for a hands-on
approach to management and delivery of results.  Raffi has held a number of
senior management roles over the last 20 years and has significant
international experience in the ventilator market.

 

Most recently Raffi was CEO of Breas Medical, a Swedish based global medical
device company designing, manufacturing, and marketing ventilation devices for
home and hospital use. During his four-year tenure he was responsible for
transformational change improving turnover and profitability while
successfully launching new products in the US with experience in navigating
the FDA regulatory processes. Prior to this, he held a leadership position at
GE Healthcare where he was responsible for setting the product growth
strategy, value proposition and marketing activities in the anaesthesia and
ventilation segment.

 

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are
delighted to welcome Raffi on board, and we look forward to him joining the
Inspiration team. He has been instrumental in developing industry-leading
respiratory solutions in his past roles and has a track record of delivery.
Raffi brings significant international commercial expertise including
successful US product launches. We believe Raffi has the right skillset to
execute on our future plans and deliver long term value to shareholders and I
look forward to working with him."

 

Raffi Stepanian, incoming Chief Executive Officer commented: "I am thrilled to
be joining Inspiration Healthcare at a stage in the Group's development where
they are turning a corner and now have a clear strategy to return the business
to growth. Inspiration has significant potential, with world class design and
manufacturing expertise and a broad range of innovative best-in-class medical
products. There are also exciting growth opportunities in new markets. I'm
looking forward to working with Roy, the Board, and the Inspiration Healthcare
team to deliver on the opportunity."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Harout Rafi
Stepanian (aged 55 years) holds / has held the following
directorships/partnerships in the last five years:

 

 Current directorships / partnerships  Previous directorships / partnerships in last 5 years
 None                                  Breas Medical Holdings AB

 

Harout Rafi Stepanian does not hold any ordinary shares in the capital of the
Company.  There are no further disclosures to be made in accordance with AIM
Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                  Tel: +44 (0)330
                                                   175 0000
 Roy Davis, Executive Chair and Interim CEO

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                      Tel: +44 (0)20
                                                   3100 2000
 Richard Lindley

 Will King

 Walbrook PR Ltd (Media and Investor Relations)    Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                                   (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                                       Mob: +44 (0) 7876 741 001
 Louis Ashe-Jepson                                 Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABCBDDBBBDGSB